Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain

Journal of Virology

Volumn 79, Issue 19, 2005, Pages 12401-12407

  De Wit, Emmie ^a,b   Munster, Vincent J ^a   Spronken, Monique I J ^a,b   Bestebroer, Theo M ^a   Baas, Chantal ^a   Beyer, Walter E P ^a   Rimmelzwaan, Guus F ^a   Osterhaus, Albert D M E ^a   Fouchier, Ron A M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Solvay Pharmaceuticals Inc   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT VACCINE;

ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; AVIAN INFLUENZA; CONJUNCTIVITIS; CONTROLLED STUDY; H7N7 INFLUENZA VIRUS A; HUMAN; IMMUNOSTIMULATION; INFLUENZA VIRUS A; MOUSE; NETHERLANDS; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; VIRUS DETECTION; VIRUS ISOLATION; VIRUS VIRULENCE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; BRAIN; DISEASE MODELS, ANIMAL; FEMALE; HEMAGGLUTININS, VIRAL; IMMUNIZATION SCHEDULE; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H7N7 SUBTYPE; INFLUENZA VACCINES; ISCOMS; KIDNEY; LIVER; LUNG; MICE; MICE, INBRED BALB C; NEURAMINIDASE; ORTHOMYXOVIRIDAE INFECTIONS; RECOMBINATION, GENETIC; SPLEEN; TRANSFECTION; VACCINES, SUBUNIT; VACCINES, SYNTHETIC;

ANAS PLATYRHYNCHOS; AVES; INFLUENZA A VIRUS; MAMMALIA;

EID: 25144476252     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.19.12401-12407.2005     Document Type: Article

References (26)

1. Crouch, C. F., J. Daly, D. Hannant, J. Wilkins, and M. J. Francis. 2004. Immune responses and protective efficacy in ponies immunised with an equine influenza ISCOM vaccine containing an 'American lineage' H3N8 virus. Vaccine 23:418-425.
2. de Wit, E., M. I. Spronken, T. M. Bestebroer, G. F. Rimmelzwaan, A. D. Osterhaus, and R. A. Fouchier. 2004. Efficient generation and growth of influenza virus A/PR/8/34 from eight cDNA fragments. Virus Res. 103:155-161.
3. Fodor, E., L. Devenish, O. G. Engelhardt, P. Palese, G. G. Brownlee, and A. Garcia-Sastre. 1999. Rescue of influenza A virus from recombinant DNA. J. Virol. 73:9679-9682.
4. Fouchier, R. A., V. Munster, A. Wallensten, T. M. Bestebroer, S. Herfst, D. Smith, G. F. Rimmelzwaan, B. Olsen, and A. D. Osterhaus. 2005. Characterization of a novel influenza a virus hemagglutinin subtype (H16) obtained from black-headed gulls. J. Virol. 79:2814-2822.
5. Fouchier, R. A., B. Olsen, T. M. Bestebroer, S. Herfst, L. van der Kemp, G. F. Rimmelzwaan, and A. D. Osterhaus. 2003. Influenza A virus surveillance in wild birds in Northern Europe in 1999 and 2000. Avian Dis. 47:857-860.
6. Fouchier, R. A., P. M. Schneeberger, F. W. Rozendaal, J. M. Broekman, S. A. Kemink, V. Munster, T. Kuiken, G. F. Rimmelzwaan, M. Schutten, G. J. Van Doornum, G. Koch, A. Bosnian, M. Koopmans, and A. D. Osterhaus. 2004. Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc. Natl. Acad. Sci. USA 101:1356-1361.
7. Hoffmann, E., G. Neumann, Y. Kawaoka, G. Hobom, and R. G. Webster. 2000. A DNA transfection system for generation of influenza A virus from eight plasmids. Proc. Natl. Acad. Sci. USA 97:6108-6113.
8. Koopmans, M., B. Wilbrink, M. Conyn, G. Natrop, H. van der Nat, H. Vennema, A. Meijer, J. van Steenbergen, R. Fouchier, A. Osterhaus, and A. Bosman. 2004. Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands. Lancet 363:587-593.
9. Li, S., C. Liu, A. Klimov, K. Subbarao, M. L. Perdue, D. Mo, Y. Ji, L. Woods, S. Hietala, and M. Bryant. 1999. Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses. J. Infect. Dis. 179:1132-1138.
10. Lipatov, A. S., R. J. Webby, E. A. Govorkova, S. Krauss, and R. G. Webster. 2005. Efficacy of h5 influenza vaccines produced by reverse genetics in a lethal mouse model. J. Infect. Dis. 191:1216-1220.
11. Liu, M., J. M. Wood, T. Ellis, S. Krauss, P. Seiler, C. Johnson, E. Hoffmann, J. Humberd, D. Hulse, Y. Zhang, R. G. Webster, and D. R. Perez. 2003. Preparation of a standardized, efficacious agricultural H5N3 vaccine by reverse genetics. Virology 314:580-590.
12. Lu, X., T. M. Tumpey, T. Morken, S. R. Zaki, N. J. Cox, and J. M. Katz. 1999. A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans. J. Virol. 73:5903-5911.
13. Morein, B., B. Sundquist, S. Hoglund, K. Dalsgaard, and A. Osterhaus. 1984. Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses. Nature 308:457-460.
14. Mumford, J. A., D. Jessett, U. Dunleavy, J. Wood, D. Hannant, B. Sundquist, and R. F. Cook. 1994. Antigenicity and immunogenicity of experimental equine influenza ISCOM vaccines. Vaccine 12:857-863.
15. Neumann, G., T. Watanabe, H. Ito, S. Watanabe, H. Goto, P. Gao, M. Hughes, D. R. Perez, R. Donis, E. Hoffmann, G. Hobom, and Y. Kawaoka. 1999. Generation of influenza A viruses entirely from cloned cDNAs. Proc. Natl. Acad. Sci. USA 96:9345-9350.
16. Nicholson, K. G., A. E. Colegate, A. Podda, I. Stephenson, J. Wood, E. Ypma, and M. C. Zambon. 2001. Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza. Lancet 357:1937-1943.
17. Nicolson, C., D. Major, J. M. Wood, and J. S. Robertson. 2005. Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system. Vaccine 23:2943-2952.
18. Rimmelzwaan, G. F., M. Baars, E. C. Claas, and A. D. Osterhaus. 1998. Comparison of RNA hybridization, hemagglutination assay, titration of infectious virus and immunofluorescence as methods for monitoring influenza virus replication in vitro. J. Virol. Methods 74:57-66.
19. Rimmelzwaan, G. F., M. Baars, R. van Beek, G. van Amerongen, K. Lovgren-Bengtsson, E. C. Claas, and A. D. Osterhaus. 1997. Induction of protective immunity against influenza virus in a macaque model: comparison of conventional and ISCOM vaccines. J. Gen. Virol. 78:757-765.
20. Rimmelzwaan, G. F., E. C. Claas, G. van Amerongen, J. C. de Jong, and A. D. Osterhaus. 1999. ISCOM vaccine induced protection against a lethal challenge with a human H5N1 influenza virus. Vaccine 17:1355-1358.
21. Rimmelzwaan, G. F., N. Nieuwkoop, A. Brandenburg, G. Sutter, W. E. Beyer, D. Maher, J. Bates, and A. D. Osterhaus. 2000. A randomized, double blind study in young healthy adults comparing cell mediated and humoral immune responses induced by influenza ISCOM vaccines and conventional vaccines. Vaccine 19:1180-1187.
22. Smith, D. J., A. S. Lapedes, J. C. de Jong, T. M. Bestebroer, G. F. Rimmelzwaan, A. D. Osterhaus, and R. A. Fouchier. 2004. Mapping the antigenic and genetic evolution of influenza virus. Science 305:371-376.
23. Stittelaar, K. J., J. Boes, G. F. Kersten, A. Spiekstra, P. G. Mulder, P. de Vries, P. J. Roholl, K. Dalsgaard, G. van den Dobbelsteen, L. van Alphen, and A. D. Osterhaus. 2000. In vivo antibody response and in vitro CTL activation induced by selected measles vaccine candidates, prepared with purified Quil A components. Vaccine 18:2482-2493.
24. Takada, A., N. Kuboki, K. Okazaki, A. Ninomiya, H. Tanaka, H. Ozaki, S. Itamura, H. Nishimura, M. Enami, M. Tashiro, K. F. Shortridge, and H. Kida. 1999. Avirulent avian influenza virus as a vaccine strain against a potential human pandemic. J. Virol. 73:8303-8307.
25. Webby, R. J., D. R. Perez, J. S. Coleman, Y. Guan, J. H. Knight, E. A. Govorkova, L. R. McClain-Moss, J. S. Peiris, J. E. Rehg, E. I. Tuomanen, and R. G. Webster. 2004. Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines. Lancet 363:1099-1103.
26. Wood, J. M., D. Major, R. W. Newman, U. Dunleavy, C. Nicolson, J. S. Robertson, and G. C. Schild. 2002. Preparation of vaccines against H5N1 influenza. Vaccine 20(Suppl. 2):S84-87.